FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.3  |  FHIR Version n/a  User: [n/a]

88757004: Sulfafurazole acetyl (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2154351010 Sulfafurazole acetyl en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2155373010 Sulfisoxazole acetyl en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3485327016 Sulfafurazole acetyl (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2851531000005111 Sulfisoxazolacetyl da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Sulfafurazole acetyl Is a Product containing sulfafurazole (medicinal product) false Inferred relationship Some
Sulfafurazole acetyl Is a Sulfafurazole false Inferred relationship Some
Sulfafurazole acetyl Is a Substance with sulfonamide structure and antibacterial mechanism of action (substance) true Inferred relationship Some
Sulfafurazole acetyl This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Sulfafurazole true Inferred relationship Some
Sulfafurazole acetyl This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Antibacterial (disposition) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
sulfisoxazolacetyl 500 mg/5 ml suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Sulfafurazole acetyl Inferred relationship Some
Sulfisoxazole acetyl 0.5g/5mL suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Sulfafurazole acetyl Inferred relationship Some
erythromycinethylsuccinat 200 mg + sulfisoxazolacetyl 600 mg oral suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Sulfafurazole acetyl Inferred relationship Some
erythromycinethylsuccinat + sulfisoxazolacetyl The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Sulfafurazole acetyl Inferred relationship Some

Reference Sets

GB English

US English

Back to Start